Narrow search
Showing 1 - 10 of 46,949
Cover Image
Evaluating the US pharmaceutical patent policy
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021
crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in … the US pharmaceutical industry. We estimate the effect of patent length and scope on generic entry prior to the expiration … of new drug patents using two quasi-experimental approaches: one based on changes in patent laws and another on the …
Persistent link: https://www.econbiz.de/10012802183
Cover Image
Optimal patent policy for pharmaceutical industry
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2020
Persistent link: https://www.econbiz.de/10012439514
Cover Image
"Napsterizing" pharmaceuticals : access, innovation, and consumer welfare
Hughes, James W.; Moore, Michael J.; Snyder, Edward A. - 2002
Persistent link: https://www.econbiz.de/10001702597
Cover Image
"Napsterizing" Pharmaceuticals : Access, Innovation, and Consumer Welfare
Hughes, James W.; Moore, Michael J.; Snyder, Edward A. - 2021
We analyze the effects on consumers of an extreme policy experiment -- Napsterizing' pharmaceuticals -- whereby all … patent rights on branded prescription drugs are eliminated for both existing and future prescription drugs without … compensation to the patent holders. The question of whether this policy maximizes consumer welfare cannot be resolved on an a …
Persistent link: https://www.econbiz.de/10013212342
Cover Image
"Napsterizing" Pharmaceuticals : Access, Innovation, and Consumer Welfare
Hughes, James W. - 2002
We analyze the effects on consumers of an extreme policy experiment -- Napsterizing' pharmaceuticals -- whereby all … patent rights on branded prescription drugs are eliminated for both existing and future prescription drugs without … compensation to the patent holders. The question of whether this policy maximizes consumer welfare cannot be resolved on an a …
Persistent link: https://www.econbiz.de/10012469480
Cover Image
Starving (or Fattening) the Golden Goose? : Generic Entry and the Incentives for Early-Stage Pharmaceutical Innovation
Branstetter, Lee - 2015
stage pharmaceutical innovation? We explore this question using novel data sources and an empirical framework that models … implications of our results for long-run welfare, policy, and innovation …
Persistent link: https://www.econbiz.de/10013032342
Cover Image
Starving (or Fattening) the Golden Goose? : Generic Entry and the Incentives for Early-Stage Pharmaceutical Innovation
Branstetter, Lee - 2014
stage pharmaceutical innovation? We explore this question using novel data sources and an empirical framework that models … implications of our results for long-run welfare, policy, and innovation …
Persistent link: https://www.econbiz.de/10012458133
Cover Image
Pharmaceutical Followers
Arcidiacono, Peter - 2013
We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and ``me-too'' drugs each increased...
Persistent link: https://www.econbiz.de/10013074647
Cover Image
Pharmaceutical Followers
Arcidiacono, Peter - 2013
We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded and generic drugs within and across therapeutic classes. We use data on antiulcer drugs from 1991 to 2010. Our simulations show generics and ``me-too'' drugs each increased...
Persistent link: https://www.econbiz.de/10012459141
Cover Image
Copyright and Trademark Issues in the Pharmaceutical Industry : Generic Compliance or Brand Drug Imitating: 'Copycat or Compliance'
Termini, Roseann B.; Miele, Amy - 2014
Imitation is the sincerest form of flattery; that is, unless the imitation is of a product produced by a multi billion-dollar industry. Then, imitation has the potential to involve intellectual property litigation. For the pharmaceutical industry, the majority of intellectual property litigation...
Persistent link: https://www.econbiz.de/10014161252